Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.21.2
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2021
Jan. 31, 2021
Sep. 30, 2020
Jan. 31, 2020
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Equity Offering                      
Common Stock shares, Outstanding         9,864,158       9,864,158   7,139,068
Finance costs attributable to issuance of warrants                 $ 0 $ 211,000  
Non-cash loss on changes in fair value of warrants         $ 0   $ 0   0 923,000  
Stock-based compensation                 1,359,000 $ 4,000  
2015 Plan                      
Equity Offering                      
Number of additional shares authorized   1,000,000                  
Common Stock                      
Equity Offering                      
Issuance of common stock, net (in shares)           2,725,000 648,000 290,000      
Common Stock | Restricted stock agreement with Maxim Group, LLC                      
Equity Offering                      
Number of shares agreed to issue 50,000                    
Vesting period 12 months                    
Stock-based compensation         $ 9,000            
January 2020 Offering                      
Equity Offering                      
Issuance of common stock, net (in shares)       290,000              
Warrants to purchase shares of common stock       290,000              
Exercise price of warrants (in dollars per share)       $ 7.50              
Proceeds from sale of common stock       $ 1,900,000              
Finance costs attributable to issuance of warrants                 $ 200,000    
Non-cash loss on changes in fair value of warrants       $ 900,000              
September 2020 Offering                      
Equity Offering                      
Issuance of common stock, net (in shares)     648,000                
Share issue price (in dollars per share)     $ 4.20       $ 4.20     $ 4.20  
Proceeds from sale of common stock     $ 2,400,000                
January 2021 Offering                      
Equity Offering                      
Issuance of common stock, net (in shares)   2,725,000                  
Warrants to purchase shares of common stock   2,725,000                  
Exercise price of warrants (in dollars per share)   $ 3.55                  
Proceeds from sale of common stock   $ 8,800,000